Healthcare provider profile · identity verified

Laura Myrick, MD

Family Practice · OKLAHOMA CITY, OK · NPI 1275768939

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	350	70
Gabapentin	Gabapentin	325	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	318	48
Lisinopril	Lisinopril	241	58
Simvastatin	Simvastatin	230	57
Atorvastatin Calcium	Atorvastatin Calcium	213	47
Sertraline Hcl	Sertraline Hcl	182	34
Potassium Chloride	Potassium Chloride	163	37
Furosemide	Furosemide	161	35
Losartan Potassium	Losartan Potassium	153	39
Omeprazole	Omeprazole	152	35
Hydrochlorothiazide	Hydrochlorothiazide	145	38
Pantoprazole Sodium	Pantoprazole Sodium	144	31
Amlodipine Besylate	Amlodipine Besylate	138	37
Metformin Hcl	Metformin Hcl	117	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	109	15
Eliquis	Apixaban	108	18
Montelukast Sodium	Montelukast Sodium	106	27
Ozempic	Semaglutide	105	19
Clopidogrel	Clopidogrel Bisulfate	97	19
Trazodone Hcl	Trazodone Hcl	92	28
Alprazolam	Alprazolam	89	20
Celecoxib	Celecoxib	88	20
Tizanidine Hcl	Tizanidine Hcl	87	14
Venlafaxine Hcl Er	Venlafaxine Hcl	76	14
Citalopram Hbr	Citalopram Hydrobromide	75	18
Carvedilol	Carvedilol	72	18
Pregabalin	Pregabalin	68	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	14
Metoprolol Succinate	Metoprolol Succinate	66	17
Metoprolol Tartrate	Metoprolol Tartrate	66	19
Meloxicam	Meloxicam	64	20
Ropinirole Hcl	Ropinirole Hcl	62	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	58	18
Allopurinol	Allopurinol	57	13
Tramadol Hcl	Tramadol Hcl	55	19
Trulicity	Dulaglutide	55	12
Mounjaro	Tirzepatide	53	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	53	12
Clonazepam	Clonazepam	50	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	50	12
Ezetimibe	Ezetimibe	47	11
Famotidine	Famotidine	44	11
Fluticasone Propionate	Fluticasone Propionate	43	21
Metformin Hcl Er	Metformin Hcl	40	11
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Memantine Hcl	Memantine Hcl	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	12
Naproxen	Naproxen	35	suppressed
Eszopiclone	Eszopiclone	34	11
Glimepiride	Glimepiride	34	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Buspirone Hcl	Buspirone Hcl	33	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	31	suppressed
Glyburide	Glyburide	30	suppressed
Levetiracetam	Levetiracetam	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Glipizide	Glipizide	28	suppressed
Atenolol	Atenolol	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Estradiol	Estradiol	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Temazepam	Temazepam	23	suppressed
Topiramate	Topiramate	23	suppressed
Diazepam	Diazepam	22	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Ondansetron Odt	Ondansetron	21	16
Triamcinolone Acetonide	Triamcinolone Acetonide	21	15
Ibuprofen	Ibuprofen	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Glipizide Er	Glipizide	18	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Azithromycin	Azithromycin	16	16
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Leflunomide	Leflunomide	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Acetazolamide	Acetazolamide	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Baclofen	Baclofen	11	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Ertapenem	Ertapenem Sodium	11	suppressed
Hysingla Er	Hydrocodone Bitartrate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lactulose	Lactulose	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error